Fig. 7

Next steps in genomic risk disclosure. The following should be considered when developing genomic risk disclosure tools: (1) Use non-stigmatizing colors that leverage neutral associations and are accessible for individuals with color blindness, (2) Report polygenic scores as percentile and avoid prescribing a categorical risk label, (3) Use interactive web-based reporting tools that enable accessibility options and personalized experiences, (4) Develop reporting tools that integrate a range of disease risk factors